Sign Up Today and Learn More About TP Therapeutics Stock
Invest in or calculate the value of your shares in TP Therapeutics or other pre-IPO companies through EquityZen's platform.
TP Therapeutics Stock
TP Therapeutics is a structure-based drug design pharmaceutical company
About TP Therapeutics Stock
Founded
2013
Headquarters
San Diego, CA, US
Total Funding
144M
Industries
TP Therapeutics, Inc. is a structure-based drug design pharmaceutical company founded by Dr. J. Jean Cui, the lead inventor of Pfizer's Xalkori(TM) (generic name: crizotinib), the precision oncology drug for non-small cell lung cancer (NSCLC). Xalkori(TM) was approved by US Food and Drug Administration on August 26th, 2011.
TP Therapeutics Management
Leadership team at TP Therapeutics
Founder & CSO
J. Jean Cui
Senior Vice President, Clinical Operations and Regulatory Affairs
John K.C. Lim
Join now and verify your accreditation status to gain access to:
- TP Therapeutics current valuation
- TP Therapeutics stock price
- Available deals in TP Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in TP Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like TP Therapeutics through EquityZen funds. These investments are made available by existing TP Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell TP Therapeutics stock?
Shareholders can sell their TP Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
